Buprenorphine transdermal skin patch and Tildrakizumab-asmn
Determining the interaction of Buprenorphine transdermal skin patch and Tildrakizumab-asmn and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Tildrakizumab-asmn Subcutaneous
- Buprenorphine transdermal skin patch-Tilia Fe
- Buprenorphine transdermal skin patch-Tiludronate
- Buprenorphine transdermal skin patch-Timentin
- Buprenorphine transdermal skin patch-Timentin Add-Vantage
- Buprenorphine transdermal skin patch-Timentin Injection
- Tildrakizumab-asmn-Buprenorphine, Buprenorphine Hydrochloride
- Tildrakizumab-asmn-Buprenorphine/naloxone Oromucosal, Sublingual
- Tildrakizumab-asmn-Buproban
- Tildrakizumab-asmn-Bupropion
- Tildrakizumab-asmn-Bupropion and naltrexone
- Tildrakizumab-asmn-Bupropion Extended-Release Tablets